
Independent Study Confirms First-Ever Black Hole Image, Validating Einstein’s Theory
By JOSEPH CURL
|This article is from the archive of The New York Sun before the launch of its new website in 2022. The Sun has neither altered nor updated such articles but will seek to correct any errors, mis-categorizations or other problems introduced during transfer.

Published:
Updated:
Abbott Laboratories agreed to pay $3.7 billion in cash for Kos Pharmaceuticals Incorporated in a bid to strengthen its cholesterol-management business.

By JOSEPH CURL
|
By DAVID JONES
|
By ELYSA GARDNER
|
By ALEXANDER LARMAN
|
By HOLLIE McKAY
|
By JOSEPH CURL
|
By DAVID JONES
|
By GEORGE WILLIS
|Abbott Laboratories agreed to pay $3.7 billion in cash for Kos Pharmaceuticals Incorporated in a bid to strengthen its cholesterol-management business.
Already have a subscription? Sign in to continue reading
Cancel anytime
By continuing you agree to our Privacy Policy and Terms of Service.
Cancel anytime